| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 05/06/2004 | US20040087509 Method of inducing and maintaining neuronal cells |
| 05/06/2004 | US20040087507 Containing amino acid; long term storage stability |
| 05/06/2004 | US20040087506 Methods of modulating FabH activity |
| 05/06/2004 | US20040087505 Agonists for coating medical devices; soluble biologics |
| 05/06/2004 | US20040087504 Novel peptide sy |
| 05/06/2004 | US20040087503 Modified ciliary neurotrophic factor (cntf ) with reduced immunogenicity |
| 05/06/2004 | US20040087500 Precise alignment using database of amino acid sequences of receptors as profiles |
| 05/06/2004 | US20040087499 Peptides that home to tumor lymphatic vasculature and methods of using same |
| 05/06/2004 | US20040087481 Modulation of cholesteryl ester transfer protein (CETP) activity |
| 05/06/2004 | US20040087478 Discovering pain regulating substances; incubating with then measuring binding to cell synthesized peptide or protein |
| 05/06/2004 | US20040087029 Production of viral vectors |
| 05/06/2004 | US20040087027 Plasmid sequences for diagnosis and treatment of hyperproliferative/cell proliferative disorders; antitumor agents |
| 05/06/2004 | US20040087026 Host cells for packing a recombinant adeno-associated virus (raav), method for the production and use thereof |
| 05/06/2004 | US20040087013 Stable macroscopic membranes formed by self-assembly of amphiphilic peptides and uses therefor |
| 05/06/2004 | US20040087002 Using attenuated viral sequence to develop vaccines to prevent porcine reproductive and respiratory syndrome in swine; immunotherapy |
| 05/06/2004 | US20040086999 Modified amino acid sequences for prevention and treatment of cancer, vision defects and inflammatory diseases |
| 05/06/2004 | US20040086998 Comprises nucleotide sequences coding regulatory elements and protein with trehalose-6-phosphate synthase activity for transformation and expression in yeast; heterologous gene expression and bioreactors |
| 05/06/2004 | US20040086988 Enzyme catalyst; polypeptides; crystal structure |
| 05/06/2004 | US20040086980 Methods for producing nucleic acids lacking 3'-untranslated regions and optimizing cellular RNA-protein fusion formation |
| 05/06/2004 | US20040086978 Pancreas-derived plasminogen activator inhibitor |
| 05/06/2004 | US20040086977 Fusion polypeptides of human serum albumin and a therapeutically active polypeptide |
| 05/06/2004 | US20040086976 Genetically engineered erythropoietin for diagnosis, prevention and treatment of thrombis, cancer, neovascularization, inflammation and autoimmune diseases |
| 05/06/2004 | US20040086975 Comprises adenoid expressed chemokine for modulating, treating and diagnosing abnormalities in inflamed or diseased tissues |
| 05/06/2004 | US20040086974 Comprises human tumor suppressor protein for treatment and prevention of cell proliferative disorders; antitumor/anticarcinogenic/antiproliferative agents |
| 05/06/2004 | US20040086973 Calmodulin-dependent protein kinase inhibitor for treatment and prevention of nervous system disorders |
| 05/06/2004 | US20040086972 Directed evolution of microorganisms |
| 05/06/2004 | US20040086971 Comprises nucleotide sequences coding extracellular matrix protein for prevention and treatment of inflammatory, immune and thrombotic disorders |
| 05/06/2004 | US20040086970 Novel cytokine receptors and nucleic acids encoding the same |
| 05/06/2004 | US20040086968 Mutants of green fluorescent protein |
| 05/06/2004 | US20040086967 Comprises polynucleotide coding tumor markers proteins for diagnosis of pancreatic and colon cancers; antiproliferative agents; wound healing or tissue regeneration |
| 05/06/2004 | US20040086966 Comprises g-protein couple receptor polypeptide for diagnosis and treatment of cell proliferative disorders; gene therapy; immunotherapy |
| 05/06/2004 | US20040086965 Casein peptide fragments with growth-influencing activity on cell cultures |
| 05/06/2004 | US20040086964 Culture product of cells; nutrient solutions; genetic engineered proteins |
| 05/06/2004 | US20040086963 Comprises nucleotide sequences coding regulatory protein which is underexpressed in senescent cells and over expressed in cancer for use as diagnostic tool in detection and treatment of cell proliferative disorders |
| 05/06/2004 | US20040086962 Methods and materials relating to gene expression |
| 05/06/2004 | US20040086961 Amino acid modified polypeptides |
| 05/06/2004 | US20040086960 Transgenic cell expressing human leukocyte antigen fusion proteins for induction of cytotoxic T cell responses against viral and tumor antigens; immunotherapy |
| 05/06/2004 | US20040086952 Monoclonal antibody comrpising affininty for 5-lipoxygenase activating polypeptide (FLAP) for diagnosis, prevention and treatment of inflamation, asthma and glomerulonephritis; gastric cytoprotective agents |
| 05/06/2004 | US20040086949 Solid phase synthesis; immunology; vaccines; for generating antibodies; kits |
| 05/06/2004 | US20040086947 Deep vein thrombosis; respiratory system disorders; anticoagulants; measuring concentration of fibrinopeptides in sample; immunoassay |
| 05/06/2004 | US20040086946 Methods of isolation of active compounds and activated targets |
| 05/06/2004 | US20040086943 Coupling agent containing secordary amide groups |
| 05/06/2004 | US20040086942 Comprises peptide mimetic which competes for binding site of immunoglobulin receptor and prevents and treats allergic disorders |
| 05/06/2004 | US20040086940 Novel g protein-coupled receptor protein and dna thereof |
| 05/06/2004 | US20040086937 Screening for antagonists and/or inhibitors of bacterial propagation and infection; mimetics |
| 05/06/2004 | US20040086936 Comprises hormone polypeptide for diagnosis, prevention and treatment of cell proliferative, neurological and endocrine disorders |
| 05/06/2004 | US20040086935 Comprises nucleotide sequences coding heterodimeric receptors for identifying modulator of tumor metastasis and inflammation |
| 05/06/2004 | US20040086934 Comprises striamin polypeptide for identifying modulator for treatment and prevention of cardiovascular, tumor and muscle disorders |
| 05/06/2004 | US20040086933 Protein and gene involved in myocyte differentiation |
| 05/06/2004 | US20040086931 Polypeptides and nucleic acids encoding same |
| 05/06/2004 | US20040086921 Comprises nucleotide sequences coding membrane proteins for diagnosis and treatment of metabolic disorders |
| 05/06/2004 | US20040086920 STARS - a muscle-specific actin-binding protein |
| 05/06/2004 | US20040086916 Polypeptide for use in diagnosis and treatment of liver cancers; the polypeptides are overexpressed in tumor and preneoplastic cells in general |
| 05/06/2004 | US20040086913 Human genes and gene expression products XVI |
| 05/06/2004 | US20040086908 Comprises chimeric interleukin receptor for diagnosis, prevention and treatment of inflammatory, arthritic, crohn's, skin and cardiovascular disorders |
| 05/06/2004 | US20040086905 Lipid-associated molecules |
| 05/06/2004 | US20040086903 Comprises nucleotide sequences coding promoter and retinoid carrier protein for identifying modulator for treatment of fertility disorders |
| 05/06/2004 | US20040086900 Generating transgenic yeast coding heterologous phosphodiesterase for identifying modulators for treatment of cardiovascular, asthma, depression and thrombotic disorders |
| 05/06/2004 | US20040086898 Comprises nucleotide sequences coding g protein coupled receptor for identifying modulator for treatment and prevention of cardiovascular, respiratory, muscle, liver, gastrointestinal, urogenital and blood disorders |
| 05/06/2004 | US20040086896 Polynucleotides and polypeptides associated with the NF-kB pathway |
| 05/06/2004 | US20040086893 Gab2 (p97) gene and methods of use thereof |
| 05/06/2004 | US20040086886 Identifying allelic modifications in ion transport proteins which cause drug induced long qt symdrome; diagnosing and prognosing cardiovascular disorders |
| 05/06/2004 | US20040086882 Comprises nucleotide sequences coding mutant multidrug resistance gene (MDR) which confers side effect reduction to anticancer drugs |
| 05/06/2004 | US20040086881 Novel human G-protein coupled receptor, BMSOTR, and splice variant thereof |
| 05/06/2004 | US20040086877 Multi-mode directi memory access controller and method |
| 05/06/2004 | US20040086876 Methods for detecting mutations associated with hypertrophic cardiomyopathy |
| 05/06/2004 | US20040086875 Novel proteins and nucleic acids encoding same |
| 05/06/2004 | US20040086863 Comprises pleckstrin homology domain-interacting protein (PHI Protein) for identifying modulator and treatment for cancer and insulin response disorders |
| 05/06/2004 | US20040086858 Identification of new human gaba transporter |
| 05/06/2004 | US20040086857 Proliferative glomerular nephritis-associated gene |
| 05/06/2004 | US20040086848 Comprises polypeptide for modulating bone loss via inhibition of osteoclast precursor cell fusion; treatment and prevention of bone disorders |
| 05/06/2004 | US20040086847 Cestrum yellow leaf curling virus promoters |
| 05/06/2004 | US20040086846 Using bacterial artificial chromosomes to propagate/replicate viral nucleotide sequences; gene therapy and genetic vaccines |
| 05/06/2004 | US20040086845 Nucleotide sequences coding fusion protein comprising translocation domain for targeting and treating tumors; antitumor agents |
| 05/06/2004 | US20040086534 Method of decreasing the severity or frequency of a relapse of multiple sclerosis |
| 05/06/2004 | US20040086530 Transgenic plant or plant cell that, when consumed as a foodstuff in four or less feedings, elicits an anti-HBsAg boosting immune response that increases serum anti-HBsAg antibody levels at least four-fold |
| 05/06/2004 | US20040086529 Vaccines containing ribavirin and methods of use thereof |
| 05/06/2004 | US20040086528 Capable of inhibiting the fusion of HIV-1 to CD4+ cells and thus of inhibiting HIV-1 infection of the cells |
| 05/06/2004 | US20040086527 Vaccine for conferring protection against human papillomavirus (HPV) infection in a human |
| 05/06/2004 | US20040086525 Polynucleotide sequences of C. pneumoniae for use in preventing and treating Chlamydia infection |
| 05/06/2004 | US20040086524 Vaccines and agents for inducing immunity in fish against rickettsial diseases, and associated preventative therapy |
| 05/06/2004 | US20040086523 Fusion proteins of mycobacterium tuberculosis |
| 05/06/2004 | US20040086522 Strategies to prevent autoimmune disease by vaccination with vaccines based upon Epstein-Barr virus |
| 05/06/2004 | US20040086521 Method for the identification of antigenic peptides |
| 05/06/2004 | US20040086515 Modified in such a way that its half-life in the vascular compartment is prolonged |
| 05/06/2004 | US20040086512 Multimerization of HIV-1 VIF protein as a therapeutic target |
| 05/06/2004 | US20040086511 Neuronal gene expression patterns |
| 05/06/2004 | US20040086510 Binds to insulin responsive aminopeptidase or GLUT4 glucose transporter 4 therapeutic agent for treatment or prophylaxis of hyperglycemia or diabetes |
| 05/06/2004 | US20040086509 Enhancing sperm motility wherein a Zins2 testis- specific insulin homolog polypeptide is added to sperm, an egg, an egg-sperm mixture, prior to fertilization |
| 05/06/2004 | US20040086507 Antibody inhibiting vplf activity |
| 05/06/2004 | US20040086506 Polyvalent immunogen |
| 05/06/2004 | US20040086505 Derived from human placenta |
| 05/06/2004 | US20040086504 Antibodies which neutralize Cyr61 activity, a growth factor-regulated immediate-early genes that play a role in development, cell proliferation, and tumorigenesis |
| 05/06/2004 | US20040086503 High-affinity human anti-IGF-IR antibodies that could be used to treat diseases in humans |
| 05/06/2004 | US20040086501 Protein having activity as an angiogenesis modulator |
| 05/06/2004 | US20040086490 Nucleic acid vector comprising a pair of adeno-associated virus 4 (AAV4) inverted terminal repeats and a promoter between the inverted terminal repeats |
| 05/06/2004 | US20040086489 Recombinant cytomegalovirus comprising a cytomegalovirus genome that comprises a heterologous nucleotide sequence encoding a heterologous chemokine receptor or ligand |
| 05/06/2004 | EP1416281A2 Assay for disease related conformation of a protein |
| 05/06/2004 | EP1416272A1 Pael receptor, cells and animal expressing pael receptor and method of screening remedy for parkinson's disease |
| 05/06/2004 | EP1416048A1 Nucleic acid participating in the formation of presenilin-2-gene exon 5-;defective splicing variant |